KE Dipeptide Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: 100 mcg - 1 mg daily (preclinical)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Thymus Stimulation / Immunomodulation (Animal Models)

100-500 mcg/kg1-2× daily

Duration

2-4 weeks

Based on rodent studies. Convert to human equivalent dose cautiously. Route of administration (e.g., subcutaneous, intraperitoneal) may affect bioavailability.

Age-Related Immune Decline (Animal Models)

100-500 mcg/kg1× daily

Duration

4-8 weeks

Used in preclinical studies investigating the effects of KE dipeptide on T-cell function and thymic regeneration in aging animals.

Experimental Oral Administration

500 mcg - 1 mg2-3x daily

Duration

Limited data available

Given the rapid degradation of dipeptides, higher doses or frequent dosing may be necessary to achieve systemic effects via oral administration. Sublingual administration may improve absorption compared to traditional oral dosing.

Timing & Frequency

In preclinical studies, KE dipeptide is often administered in the morning or divided into multiple doses throughout the day to account for its short half-life. For oral administration, dosing on an empty stomach may improve absorption.

Cycle Guidance

Due to the limited data on long-term effects, cycling is recommended as a precautionary measure. A typical cycle might involve 4-8 weeks of administration followed by a 2-4 week break. No established cycling protocols exist for KE dipeptide in humans.

Reconstitution Reference

Quick reference for reconstituting KE Dipeptide. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	Typically supplied as a lyophilized powder
BAC Water Volume	Dependent on desired concentration; consult manufacturer instructions
Concentration & Draw	Variable, depending on the amount of diluent used. Example: Dissolving 1 mg in 1 mL of sterile water yields a concentration of 1 mg/mL.
Storage	Refrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
Stability	Reconstituted solution should be used promptly. Lyophilized powder stable per manufacturer specifications.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the typical dosage of KE dipeptide?

There is no established human dosage for KE dipeptide. Preclinical research in animal models uses dosages ranging from 100 mcg to 1 mg per kilogram of body weight per day. These dosages are for research purposes only and should not be extrapolated to humans without proper clinical trials.

How should KE dipeptide be administered?

In preclinical studies, KE dipeptide has been administered via subcutaneous, intraperitoneal, and oral routes. The optimal route of administration for humans is unknown. Given its rapid degradation, oral bioavailability may be limited. Sublingual administration may be a viable option, but more research is needed.

What is the half-life of KE dipeptide?

KE dipeptide has a very short half-life, likely on the order of minutes, due to rapid degradation by peptidases. This necessitates frequent dosing to maintain therapeutic levels.